Skip to main content
Rigel Pharmaceuticals, Inc. (RIGL)
NASDAQ: RIGL · Real-Time Price · USD
30.56
+0.05 (0.16%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Rigel Pharmaceuticals Revenue

In the year 2025, Rigel Pharmaceuticals had annual revenue of $294.28M with 64.15% growth. Rigel Pharmaceuticals had revenue of $69.80M in the quarter ending December 31, 2025, with 21.19% growth.

Revenue (ttm)
$294.28M
Revenue Growth
+64.15%
P/S Ratio
1.92
Revenue / Employee
$1,691,276
Employees
174
Market Cap
564.75M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025294.28M115.00M64.15%
Dec 31, 2024179.28M62.40M53.38%
Dec 31, 2023116.88M1.14M0.98%
Dec 31, 2022115.74M-22.99M-16.57%
Dec 31, 2021138.74M30.12M27.72%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Zevra Therapeutics 106.47M
Sutro Biopharma 102.48M
Prothena Corporation 9.68M
Adlai Nortye 5.00M
Ocugen 4.41M
Shattuck Labs 1.00M
ProKidney 893.00K
Altimmune 41.00K
Revenue Rankings

RIGL News

More News